BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 16458792)

  • 1. Spatial analysis of prostate cancer incidence and race in Virginia, 1990-1999.
    Oliver MN; Smith E; Siadaty M; Hauck FR; Pickle LW
    Am J Prev Med; 2006 Feb; 30(2 Suppl):S67-76. PubMed ID: 16458792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Geographic bias related to geocoding in epidemiologic studies.
    Oliver MN; Matthews KA; Siadaty M; Hauck FR; Pickle LW
    Int J Health Geogr; 2005 Nov; 4():29. PubMed ID: 16281976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spatial patterns in prostate Cancer-specific mortality in Pennsylvania using Pennsylvania Cancer registry data, 2004-2014.
    Wang M; Wasserman E; Geyer N; Carroll RM; Zhao S; Zhang L; Hohl R; Lengerich EJ; McDonald AC
    BMC Cancer; 2020 May; 20(1):394. PubMed ID: 32375682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostate Cancer Incidence and Aggressiveness in Appalachia versus Non-Appalachia Populations in Pennsylvania by Urban-Rural Regions, 2004-2014.
    McDonald AC; Wasserman E; Lengerich EJ; Raman JD; Geyer NR; Hohl RJ; Wang M
    Cancer Epidemiol Biomarkers Prev; 2020 Jul; 29(7):1365-1373. PubMed ID: 32277006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence variation of prostate and cervical cancer according to socioeconomic level in the Girona Health Region.
    Vicens GR; Zafra MS; Moreno-Crespi J; Ferrer BC; Marcos-Gragera R
    BMC Public Health; 2014 Oct; 14():1079. PubMed ID: 25325921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of study area size on geographic characterizations of health events: prostate cancer incidence in Southern New England, USA, 1994-1998.
    Gregorio DI; Samociuk H; DeChello L; Swede H
    Int J Health Geogr; 2006 Feb; 5():8. PubMed ID: 16480512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploring Smoking Disparities and Sociodemographic Factors in a Peri-urban Landscape: A Census Tract-Level Analysis in McLennan County, Texas.
    Williamson JI; Janda KM; Jones SK
    J Community Health; 2024 Apr; 49(2):286-295. PubMed ID: 37932627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Geographical clustering of prostate cancer grade and stage at diagnosis, before and after adjustment for risk factors.
    Klassen AC; Kulldorff M; Curriero F
    Int J Health Geogr; 2005 Jan; 4(1):1. PubMed ID: 15649329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploratory analysis of the spatial distribution of adult glioma age-adjusted county incidence rates, Nebraska Medicine, 2009-2019.
    Ratnapradipa KL; Yellala A; Shonka N
    Neurooncol Pract; 2024 Feb; 11(1):64-68. PubMed ID: 38222054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Racial/Ethnic Disparities in Prostate Cancer 5-Year Survival: The Role of Health-Care Access and Disease Severity.
    El Khoury CJ; Clouston SAP
    Cancers (Basel); 2023 Aug; 15(17):. PubMed ID: 37686560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spatial analysis of colorectal cancer outcomes and socioeconomic factors in Virginia.
    Thatcher EJ; Camacho F; Anderson RT; Li L; Cohn WF; DeGuzman PB; Porter KJ; Zoellner JM
    BMC Public Health; 2021 Oct; 21(1):1908. PubMed ID: 34674672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Augmenting disease maps: a Bayesian meta-analysis approach.
    Jahan F; Duncan EW; Cramb SM; Baade PD; Mengersen KL
    R Soc Open Sci; 2020 Aug; 7(8):192151. PubMed ID: 32968502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Forecasting annual incidence and mortality rate for prostate cancer in Australia until 2022 using autoregressive integrated moving average (ARIMA) models.
    Earnest A; Evans SM; Sampurno F; Millar J
    BMJ Open; 2019 Aug; 9(8):e031331. PubMed ID: 31431447
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Geographical Variations in Prostate Cancer Outcomes: A Systematic Review of International Evidence.
    Dasgupta P; Baade PD; Aitken JF; Ralph N; Chambers SK; Dunn J
    Front Oncol; 2019; 9():238. PubMed ID: 31024842
    [No Abstract]   [Full Text] [Related]  

  • 15. Impact of individual and neighborhood factors on socioeconomic disparities in localized and advanced prostate cancer risk.
    DeRouen MC; Schupp CW; Yang J; Koo J; Hertz A; Shariff-Marco S; Cockburn M; Nelson DO; Ingles SA; Cheng I; John EM; Gomez SL
    Cancer Causes Control; 2018 Oct; 29(10):951-966. PubMed ID: 30136012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spatial-temporal analysis of prostate cancer incidence from the Pennsylvania Cancer Registry, 2000-2011.
    Wang M; Matthews SA; Iskandarani K; Li Y; Li Z; Chinchilli VM; Zhang L
    Geospat Health; 2017 Nov; 12(2):611. PubMed ID: 29239571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rural-Urban Differences in Cancer Incidence and Trends in the United States.
    Zahnd WE; James AS; Jenkins WD; Izadi SR; Fogleman AJ; Steward DE; Colditz GA; Brard L
    Cancer Epidemiol Biomarkers Prev; 2018 Nov; 27(11):1265-1274. PubMed ID: 28751476
    [No Abstract]   [Full Text] [Related]  

  • 18. Residential Segregation and Racial Cancer Disparities: A Systematic Review.
    Landrine H; Corral I; Lee JGL; Efird JT; Hall MB; Bess JJ
    J Racial Ethn Health Disparities; 2017 Dec; 4(6):1195-1205. PubMed ID: 28039602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Place-Oriented, Mixed-Level Regionalization Method for Constructing Geographic Areas in Health Data Dissemination and Analysis.
    Mu L; Wang F; Chen VW; Wu XC
    Ann Assoc Am Geogr; 2014; 105(1):48-66. PubMed ID: 26251551
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.